Literature DB >> 11927308

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Weber K Lau1, John C Cheville, Michael L Blute, Amy L Weaver, Horst Zincke.   

Abstract

OBJECTIVES: To assess the effect of renal cell carcinoma (RCC) subtype, tumor size, and Fuhrman grade on clinical outcome in patients with pathologic T1 (pT1) RCC treated with radical nephrectomy.
METHODS: Between 1970 and 1998, 840 patients underwent radical nephrectomy for pT1 RCC. Tumors were subtyped and graded. Univariate and multivariate Cox proportional hazards models were fitted to assess the features associated with metastasis-free survival (MFS) and cancer-specific survival (CSS). We identified a range of tumor sizes of clear cell RCC in which a transition occurred from low to high risk. Cox proportional hazards models were then fitted by using size cutoffs.
RESULTS: The mean follow-up (+/- SD) was 9.4 +/- 6.6 years among the patients alive at latest follow-up. At 10 years, the CSS and MFS for clear cell RCC (n = 682) were 89.1% and 88.6%, respectively; for papillary RCC (n = 122), they were 95.5% and 93.8%; and for chromophobe RCC (n = 33), they were both 100%. The differences in CSS (P = 0.013) and MFS (P = 0.023) between clear cell RCC and the other subtypes were statistically significant. For clear cell RCC, tumor size and Fuhrman grade were independently associated with CSS and MFS (P <0.001). A transition in risk occurred for tumor sizes between 4.5 and 5.0 cm, and the tumor size cutoff of 5.0 cm had the highest concordance index for predicting CSS and MFS.
CONCLUSIONS: RCC subtype is a strong independent prognostic variable for patients with pT1 RCC treated with radical nephrectomy. For clear cell RCC, Fuhrman grade and tumor size are independently associated with CSS and MFS.

Entities:  

Mesh:

Year:  2002        PMID: 11927308     DOI: 10.1016/s0090-4295(01)01589-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  23 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases.

Authors:  Andrea Veltri; Irene Garetto; Irene Tosetti; Marco Busso; Alessandro Volpe; Donatella Pacchioni; Enrico Bollito; Mauro Papotti
Journal:  Eur Radiol       Date:  2010-09-01       Impact factor: 5.315

3.  Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit.

Authors:  Amaka T Fadahunsi; Thomas Sanford; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

Review 4.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

5.  Gender discrepancies in the diagnosis of renal cortical tumors.

Authors:  Phillip M Pierorazio; Alana M Murphy; Mitchell C Benson; James M McKiernan
Journal:  World J Urol       Date:  2007-03       Impact factor: 4.226

6.  Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Tetsuro Tomonaga; Hakushi Kim; Kazuya Hanai; Yukio Usui; Yoshihiro Nagata; Masaki Miyazawa; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toyoaki Uchida; Toshiro Terachi; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2013-01-01       Impact factor: 5.150

Review 7.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

Review 8.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

9.  Feasibility and outcomes of repeat partial nephrectomy.

Authors:  Aaron Johnson; Sunil Sudarshan; Jack Liu; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

10.  Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Authors:  Zhong Jiang; Christine M Lohse; Peigou G Chu; Chin-Lee Wu; Bruce A Woda; Kenneth L Rock; Eugene D Kwon
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.